POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612,305 | +35.2% | 257,271 | 0.0% | 0.02% | +33.3% |
| Q2 2023 | $452,797 | -42.9% | 257,271 | 0.0% | 0.01% | -45.5% |
| Q1 2023 | $792,395 | -43.6% | 257,271 | -3.0% | 0.02% | -48.8% |
| Q4 2022 | $1,405,936 | +51.3% | 265,271 | +0.8% | 0.04% | +30.3% |
| Q3 2022 | $929,000 | +38.7% | 263,271 | +1.4% | 0.03% | +43.5% |
| Q2 2022 | $670,000 | -42.4% | 259,571 | +0.0% | 0.02% | -32.4% |
| Q1 2022 | $1,163,000 | -34.2% | 259,491 | 0.0% | 0.03% | -33.3% |
| Q4 2021 | $1,767,000 | -9.7% | 259,491 | -3.3% | 0.05% | -17.7% |
| Q3 2021 | $1,956,000 | -24.0% | 268,290 | +4.5% | 0.06% | -23.5% |
| Q2 2021 | $2,573,000 | +4.9% | 256,772 | +0.0% | 0.08% | -11.0% |
| Q1 2021 | $2,452,000 | – | 256,771 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |